Resources
Watch our videos to learn from our researchers, find answers to your frequently asked questions and use our glossary find out more about what precision medicine means.
Videos and stories
About Luminesce Alliance and Precision Medicine for Children
Our patients and families
Learn about the impact of precision medicine for patients and families
Psychosocial implications for patients and families
New-born screening for SMA and PID
Genetic Retinal Diseases
Our current research – enabling platforms
Luminesce Alliance Enabling Platforms create a precision medicine ecosystem transcending organisational boundaries, enhancing access to scientific resources for paediatric researchers and clinicians.
Introducing Enabling Platforms to enable faster precision medicine research and translation
Data Platform – harnessing innovative digital technologies to deliver solutions faster
Health Systems Implementation and Economics Platform to inform sustainable, scalable paediatric research translation
Our completed research
Luminesce Alliance formed the Centre for Paediatric Precision Medicine, delivering an initial four-year Paediatric Precision Medicine Program. Supported by NSW Government we funded 18 Paediatric Precision Medicine research projects focused on early diagnosis and treatment for children, limiting long-term effects and reducing the burden on the healthcare system.
Pre-disposition screening for paediatric cancers
Developing a clinical trials infrastructure for paediatric precision medicine
Computational Biology program to make sense of big data
Luminesce Alliance Conference 7 – 8 November 2024
Watch our recorded conference presentations to learn about coordinated paediatric precision medicine research in NSW and beyond.
- Session 1.0 Keynote Dr Kim Sutherland, NSW Health; Advanced Therapeutics
- Session 2.1 Precision Therapy for Cancer Therapeutic and Innovative Applications
- Session 2.2 Conference Abstracts Presentations
- Session 3.1 Functional Genomics and Precision Therapy: Cell And Gene Therapy Advancements
- Session 3.2 Innovation and Commercialisation Opportunities: Paediatric Cancer Drug Discovery Innovation
- Session 4.1 No one left behind: truly engaging families in precision medicine
- Session 4.2 Innovation and Commercialisation Opportunities
- Session 5.1 Precision medicine informed by real world data
- Session 5.2 Kids Advanced Therapeutics Pipeline N=1 clinical trials in paediatric advanced therapies
- Session 6.1 HSIE and Precision Therapy – Delivering outcomes focused sustainability for children
- Session 6.2 Conference Abstracts Presentations
- Session 7.1 The road ahead in genomics and genetic testing
- Session 7.2 Health Systems Implementation and Economics (HSIE) & Psychosocial Workshop
- Closing Session Reflections and next steps for paediatric precision medicine and Prize Awards